National Institute on Drug Abuse; Notice of Closed Meetings
Federal Register, Volume 80 Issue 102 (Thursday, May 28, 2015)
Federal Register Volume 80, Number 102 (Thursday, May 28, 2015)
Notices
Page 30473
From the Federal Register Online via the Government Publishing Office www.gpo.gov
FR Doc No: 2015-12900
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; GOMED: Grand Opportunity in Medications Development for Substance-Related Disorders (U01).
Date: July 16, 2015.
Time: 9:00 a.m. to 10:30 a.m.
Agenda: To review and evaluate cooperative agreement applications.
Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, Bethesda, MD 20814.
Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, (301) 451-3086, ruizjf@nida.nih.gov.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01) (PAR-13-334).
Date: July 16, 2015.
Time: 10:45 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, Bethesda, MD 20814.
Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, (301) 451-3086, ruizjf@nida.nih.gov.
Name of Committee: National Institute on Drug Abuse Special Emphasis Panel; NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UH2/UH3).
Date: July 16, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate cooperative agreement applications.
Place: Hilton Garden Inn Bethesda, 7301 Waverly Street, Bethesda, MD 20814.
Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, (301) 451-3086, ruizjf@nida.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS)
Dated: May 22, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 2015-12900 Filed 5-27-15; 8:45 am
BILLING CODE 4140-01-P
